The U.S. Transportation Security Administration (TSA) screened 250,467 travelers on Friday, the first time the number has surpassed 250,000 since March 24, according to daily data on its website. Delta is adding roughly 100 more daily flights in June versus May, including service out of its Atlanta hub and New York's John F. Kennedy International Airport to Florida, even as its overall second-quarter schedule is expected to be 85% smaller than last year....
We view the current action in silver as bearish, not bullish, especially since the gold to silver ratio moved back to the very strong support level (100)....
(Bloomberg) -- Moderna Inc. got a new Wall Street-high price target from Goldman Sachs as its shares traded at a record after the biotech company revealed positive early results from its experimental vaccine for Covid-19.An initial look at mRNA-1273, as the inoculation is known, “hits the mark,” analyst Salveen Richter said, raising her price target to $105 from $63, or 27% above the prior Street high of $83. Richter rates Moderna a buy. Piper Sandler analysts soon followed raising their price target to $102 from $57 saying Moderna could have “potential blockbuster vaccine sales next year.”The Nasdaq Biotechnology Index rose as much as 2.8% and is on track to close at a record high after Moderna’s test results. Moderna shares rose as much as 30%. The entire U.S. stock market rose as the first look at a potential vaccine for the disease responsible for the pandemic kindles hope for an end...
